Literature DB >> 7965440

LSD flashback syndrome exacerbated by selective serotonin reuptake inhibitor antidepressants in adolescents.

H Markel1, A Lee, R D Holmes, E F Domino.   

Abstract

Two adolescents with a long history of abuse of lysergic acid diethylamide (LSD) and symptoms consistent with major depressive disorder, on initiation of antidepressant therapy with selective serotonin reuptake inhibitor agents, had the new onset or worsening of LSD flashback syndrome. The similarity in neuroreceptor physiology for both LSD and serotonin suggests that the LSD flashback syndrome may be induced by these drugs in patients with a history of LSD abuse.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7965440     DOI: 10.1016/s0022-3476(94)70083-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  6 in total

1.  New Onset LSD Flashback Syndrome Triggered by the Initiation of SSRIs.

Authors:  Sarah Goldman; David Galarneau; Richard Friedman
Journal:  Ochsner J       Date:  2007

2.  Serotonergic/glutamatergic interactions: potentiation of phencyclidine-induced stimulus control by citalopram.

Authors:  J C Winter; J R Eckler; K C Rice; R A Rabin
Journal:  Pharmacol Biochem Behav       Date:  2005-07       Impact factor: 3.533

3.  Hallucinogen-persisting perception disorder.

Authors:  Leo Hermle; Melanie Simon; Martin Ruchsow; Martin Geppert
Journal:  Ther Adv Psychopharmacol       Date:  2012-10

4.  Distressing Visual Hallucinations after Treatment with Trazodone.

Authors:  Gustavo Santos; Ana Maria Moreira
Journal:  Case Rep Psychiatry       Date:  2017-06-18

Review 5.  Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives.

Authors:  Giovanni Martinotti; Rita Santacroce; Mauro Pettorruso; Chiara Montemitro; Maria Chiara Spano; Marco Lorusso; Massimo di Giannantonio; Arturo G Lerner
Journal:  Brain Sci       Date:  2018-03-16

6.  Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants.

Authors:  Felix Müller; Elias Kraus; Friederike Holze; Anna Becker; Laura Ley; Yasmin Schmid; Patrick Vizeli; Matthias E Liechti; Stefan Borgwardt
Journal:  Psychopharmacology (Berl)       Date:  2022-01-25       Impact factor: 4.415

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.